Cancer

Nayara has raised pre-seed funding to expand its AI patient support platform, designed to help people manage their healthcare needs between clinical appointments. The UK-based healthtech company develops AI-powered companions for hospitals, healthcare systems and medical technology companies. Its technology answers routine questions, provides personalised guidance and emotional support, and proactively checks in with patients. [...]

More than 20,000 NHS patients will take part in a blood test trial across at least 200 GP practices in England to assess whether cancers can be detected earlier. The government-funded STRIDE-RCT trial will investigate whether blood tests can identify signs of several cancers from a single sample, helping GPs decide which patients need urgent [...]

A protein that helps cancer cells divide could offer an early warning that widely used breast cancer drugs are losing their effect. Researchers found that higher activity of CDK1, a protein involved in cell division, was associated with more aggressive cancers and poorer patient outcomes. The findings could eventually help doctors identify which patients may [...]

People from minority ethnic backgrounds in England were up to 33 per cent less likely to have breast cancer diagnosed through routine screening, a study found. The research also found that people from marginalised groups were more likely to be diagnosed following an urgent suspected cancer referral or an emergency presentation. Researchers suggest that inequalities [...]

Dotplot and John Bell & Croyden are inviting women to attend breast health focus groups to help shape new technology. The femtech startup is developing a handheld device designed to make breast self-checks more consistent, helping women better understand their bodies and feel more confident about acting when something changes. The partnership aims to gather [...]

UK researchers have secured £800,000 to use AI to study breast cancer recurrence, focusing on why some oestrogen receptor-positive tumours return years after treatment. The funding will support two projects examining how cancer cells survive treatment, remain dormant and later begin growing again. Most breast cancers do not return after treatment, but some cells can [...]

Posted in partnership with Jeen Health NHS England has launched a National Inherited Cancer Predisposition Register, a national record of people carrying gene variants that raise their cancer risk. It covers around 120 cancer susceptibility genes. People on it are tracked, invited for screening and offered faster access to personalised treatment and trials, and those [...]

A rare form of triple-negative breast cancer may not need the same treatment approach as more common forms of the disease, a study suggests. Researchers analysed long-term outcomes in 24 patients with adenoid cystic carcinoma of the breast, or breast ACC, diagnosed between 2000 and 2020. Despite all patients having triple-negative breast cancer, estimated disease-specific [...]

Breast cancer rates among women under 50 in England rose between 2001 and 2023, an analysis of NHS data found. Cases increased from 42 per 100,000 women under 50 in 2001 to 47.5 per 100,000 in 2023. The analysis also found increases in several other cancers among adults under 50, although most cancers are still [...]

The UK government has launched a three-year partnership with Breast Cancer Now to improve breast cancer awareness and support for women during and after treatment.  The Department of Health and Social Care said it is the first partnership to help deliver its Renewed Women’s Health Strategy. Women will receive practical information on checking their breasts, [...]